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Abstract 
 
Aspergillus niger lipase naturally exists as an extracellular 1,3-specific lipase with molecular 
weight of 35-40 kDa. The optimal temperature for ANL activity lies between 30°C-50°C, 
while the optimal pH is between 5.0-6.0.  As the native Aspergillus niger lipase contains 
sugar modified residues, here the aim is to determine the impacts of N-linked glycosylation of 
ANL in Pichia pastoris. ANL variants generated in this study are single or double 
combination of asparagine mutations which as N59Q, N150Q, N269Q are referred to ANL1, 
ANL2 and ANL3 respectively. These asparagine sites were predicted using glycolsylation 
servers NetNGlyc and GlycoEP. Native ANL, as well as two other mutants (ANL2, ANL1-2) 
out of three mutants (ANL1, ANL2 and ANL3) are obtained in high purity through routine 
molecular biology and protein engineering tools including site-directed mutagenesis, ligation-
independent cloning, heterologous protein expression and affinity purification methods. For 
characterization of glycosylation patterns, native and mutant ANL were treated with EndoHf 
and analyzed with SDS-PAGE. The native ANL and the mutants were also used in lipase 
assays to determine thermostability. The results indicated that the mutations possess 
differential glycosylation patterns than those of the native lipase. According to the SDS-
PAGE analysis, native ANL was observed at 35-40 kDa with a smear appearance, while the 
mutants that contain N150Q were between 30-35 kDa and the other mutants did not change 
the native features. This result indicates that mutation in the 150th aminoacid has significant 
effect to alter the glycosylation of ANL. After EndoHf treatment, the smear appearances of 
the native the mutants disappeared, and all of the proteins were observed as single band at 35 
kDa. The thermostability results showed that all of the lipases including the native ANL had 
the maximal activity at 30-45°C, indicating that the mutations did not have any effect on 
thermostability of the native ANL until 50oC. N-linked glycosylation site (N150Q) in ANL 
had a major impact in glycosylation of ANL in P. pastoris, while the other two mutations 
(N59Q, N269Q) were not included in glycosylation mechanism. Finally, the scope of this 
thesis could be used to generate mutations with altered post-translational modifications and 
thus altered stability. As a result, the findings of this thesis would impose implications in 
enzymology which aims to design enzymes with optimal features.  
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ASPERGILLUS NIGER LIPAZ’IN PICHIA PASTORIS’DEKI N-BAĞLI 
GLIKOZILASYON ILE ILGILI ARAŞTIRMA 
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Özet 
 
Aspergillus niger lipazı doğal olarak 35-40 kDa moleküler ağırlığında olan 1,3 özlü 
ekstraselüler bir enzimdir. ANL’nin sıcaklığa karşı optimum aktivitesi 30oC-50oC aralığında 
ve ANL’nin pH’a karşı optimum aktivitesi 5.0-6.0’dır. Asıl Aspergillus niger lipazı şeker 
içermektedir; bu sebepten dolayı bizim buradaki amaçımız N-bağlı glikozilasyonın Pichia 
pastoris’deki etkilerini belirlemektir. Bu araştırma içerisinde tekli ve çiftli asparajinin 
mutasyonuna (ANL1, ANL2 ve ANL3) bağlı olarak değişiklik gösteren ANL’ler üretilmiştir. 
Bu asparajin lokasyonları NetNGlyc 1.0 sunucusu ve GlycoEP sunucusu aracılığıyla elde 
edilmiştir. ANL ile birlikte üç mutant ANL’nin ikisi (ANL2, ANL1-2), protein mühendisliği 
rutin yöntemlerinden olan yönlendirilmiş mutagenez, ligasyondan bağımsız klonlama, 
heterolog protein ekspresyonu, afinite purifikasyonu kullanılarak yüksek saflıkta elde 
edilmiştir. Glikozilasyon desenlerinin karakterizasyonu için, asıl ve mutant ANL’ler EndoHf 
ile işlenmiş olup analizleri SDS-PAGE ile yapılmıştır. Ayrıca asıl ve mutant ANL’lerin 
termostabilitesi denemeleri yapılmıştır. Sonuçlara göre mutasyona uğrayan ANL’lerin 
glikozilasyon desenleri asıl ANL’den farklılık göstermektedir. SDS-PAGE analizlerine göre, 
asıl ANL bulanık bir görüntüyle 35-40 kDa  arasında görünmekte olup, N150Q mutasyonuna 
sahip olan ANL bulanık bir görüntüyle 30-35 kDa arasında görünmektedir. Diğer mutasyona 
sahip ANL örnekleri asıl ANL’den farklılık göstermemektedir. Bu sonuç 150. aminoacidin  
ANL’nin glikozilasyonunu değiştirerek etki ettiğini göstermektedir. EndoHf işleminden 
sonra, bulanık olan görüntü kaybolmakta ve bütün proteinler  tek bir şerit halinde 35 kDa 
olarak gözlenmiştir. Termostabilite sonuçlarına göre asıl ANL’de dahil olmak üzere tüm 
lipazlar maksimum aktiviteye 30-45oC arasında sahiptir. Bu durumda mutasyonların 50 
dereceye kadar termostabiliteye bir etkisi olmadığı görülmektedir. P. pastoris’deki ANL’nin 
içerisindeki N-bağlı glikozilasyon yerinin (N150Q) glikozilasyona etkisi büyük olup, diğer iki 
mutasyonun glikozilasyon mekanizmasında önemi yoktur. Son olarak, bu çalışma translasyon 
sonrası modifikasyonları içeren dolayısıyla stabilite değişimini sağlayacak mutasyonların 
üretimini kapsamaktadır. Böylelikle bu çalışma, optimal özellikteki enzimlerin tasarımını 
hedefleyerek, enzimoloji dalındaki uygulamalara katkı sağlayacaktır. 
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1 INTRODUCTION 
 
1.1 Lipases 
1.1.1 Background 
 
Lipases are metabolic enzymes that are found in every domain of life. Various types of lipases 
are obtained from animals, plants and microorganisms. Lipases were discovered in the early 
20th century by Eijkmann while he was simply observing the several bacteria which are able 
to produce and secrete lipases and the degradation of lipids by the help of these produced 
enzymes. Microbial enzymes are one of the most prominent and the largest classes of 
enzymes because of the diverse variety of microbes which are identified and studied in detail 
[1, 2]. 
Lipases or triacylglycerol acylhydrolases (EC 3.1.1.3) are hydrolytic enzymes that catalyze 
reversibly the cleavage of ester bonds of triglycerides on water-insoluble substrates. During 
the digestion, transportation and processing of triglycerides lipases have a crucial role. 
Bacteria, fungi and yeast are the organisms which take a high responsibility to produce 
lipases. Since lipases come from different sources, they can operate in wide range of 
environmental conditions (pH and temperature) [3, 4].  
 
1.1.2 Reactions 
 
Lipase is the enzyme which hydrolyzes triacylglycerols (TAG) to free fatty acids (FA), 
diacylglycerols (DAG), monoacylglycerols (MAG) and glycerol [5]. Hydrolysis is an 
equilibrium reaction; therefore concentration of reactants and products may lead to change 
and affect the reaction. In this equilibrium one reactant is water; therefore, changing the 
hydrolytic conditions of the reaction shifts the equilibrium from forward to reverse or vice 
versa [6]. 
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Apart from hydrolysis, the reverse reaction perfoming (esterification, transesterification and 
its sub-divides such as acidolysis, interesterification, alcoholysis) can be catalyzed by lipases 
in anhydrous organic solvents, biphasic systems and micellar solution (Figure 1.1) [7.8]. 
 
 
Figure 1.1: Different Lipase-catalyzed Reactions in Aqueous and Non-aqueous Solutions.  
In aqueous solutions, the equilibrium moves towards ester hydrolysis, and in non-aqueous 
solutions the equilibrium moves towards ester synthesis. Lipases are capable of catalyzing 
acyl transfer reactions to synthesize new esters in organic solvents [7]. 
 
Lipases can be seen in different roles during hydrolysis reaction or esterification. During 
esterification lipases are in the habit of forming carboxylic ester bonds and catalyzing acyl 
transfer reactions whereas during hydrolysis reaction lipases break carboxylic ester bonds. 
The natural substrates of the lipases are the triacylglycerols [9, 10]. The process is followed as 
formation of an unstable acyl-enzyme intermediate, breakdown of free enzyme and acid in 
hydrolysis or to free enzyme and an ester in esterification and transesterification.  
As mentioned earlier, chemical properties of the reactants and presence of water can affect the 
results of reactions in the lipase-catalyzed reactions. When there is limited amount of 
accessible water the reaction, the reaction may produce carboxyl/thiolester or amide. The 
ester group is able to form the acyl-enzyme intermediate due to releasing an acid by the acyl 
donor (water as acyl acceptor) or forming a new ester [9]. 
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Transesterification is the conversion of a carboxylic acid ester into a different carboxylic acid 
ester.  The most common method of transesterification is the reaction of the ester with 
an alcohol in the presence of an acid catalyst as shown in Figure 1.1.  
Apart from, the hydrolysis and the synthesis of carboxylic esters, lipases can also utilize 
compounds excluding water and alcohol as nucleophiles through various reactions including 
aminolysis, thiotransesterification and oximolysis in organic solvents with selectivity [7].  
 
1.1.3 Mechanism 
 
Eventhough lipases catalyze diverse set of reactions; the fact that each reaction mechanism 
has its own properties means that lipases are distinctive from one another. Catalytic 
machinery is conserved for all lipases and is composed of serine, histidine and 
aspartate/glutamate aminoacids [11]. In order to lower the pKa of the serine hydroxyl, 
histidine and aspartate/glutamate are aligned. Thus nucleophilic attacks on the ester bond can 
be carried out by the serine. The acyl donor, the substrate, interacts with the active site of the 
lipase, forming the enzyme-substrate (ES) complex. In the catalytic triad, histidine activates 
the hydroxyl group of serine which leads to serine to carry out a nucleophilic attacks on the 
carbonyl carbon of the substrate. Thus the formation of the first tetrahedral intermediate is 
demonstrated. The main-chain amide groups of two residues create a hole which stabilizes the 
negative charge on the oxyanion. On the other hand the positive charge on the histidine is 
stabilized by the aspartate/glutamate. Another intermediate is determined by the first leaving 
group of the substrate after the decomposition of tetraheadral intermediate. However due to 
the formation of the acyl enzyme intermediate, a second tetrahedral intermediate is formed. 
This formed intermediate has the highest energy barrier in the reaction. In order to yield the 
deacylated-free form of the enzyme and the hydrolysis of the second substrate, an acid, this 
intermediate is also collapsed.  There is a transfer of the proton from the substrate to histidine 
during the deacylation step. 
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Figure 1.2: Mechanism of hydrolysis by lipases.  
During Step A, His residue acts as a general base and removes a proton from the active site of 
Ser. In Step B, an acyl-enzyme intermediate is formed, followed by the deacetylation (Step 
C). With a nucleophile attacking the acetylated enzyme, the catalytic site is regenerated and a 
long-chain fatty acid is formed as a product (Step D). [7] 
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1.1.4 Substrate Selectivity 
 
Lipases show different selectivity towards their ligands (certain fatty acids or groups of fatty 
acids) such as the type and chain-length of the acyl group in their substrates. To illustrate that 
a lipase called porcine has specificity to cis-2 over cis-7 octadecenoyl moiety [2] and also the 
Aspergillus flavus lipase exhibits higher selectivity for tricaprin than the triolein [16]. 
Furthermore, primary alcohols are mostly preferred by lipases, but tertiary alcohols are least 
preferred by lipases [5]. Lipases can accommodate not only triglycerides and aliphatic esters 
in their catalytic pockets but also the different compounds such as alicylic, bicyclic and 
aromatic esters as well as thioesters and activated amines, suggesting that they possess a 
preference over a wide range of substrate molecules [14–16]. Many studies in the literature 
focus on the chain-length selectivity of lipases [17-20]. The range of the chain-length which is 
preferred by lipases changes from short (C4) to is a range of medium (C8) to long (C16) 
chain-length of fatty acids [2]. Apart from all of these general knowledge there are some 
exceptions can be seen such as R. miehei lipase can hydrolyze esters of long chain fatty acids 
as long as C22 [21].  
 
 
 
1.1.5 Structure 
The first lipase structure has been crystallized by Brady in 1990 [11]. Nowadays it is possible 
to find more than one hundred crystallized lipase structures in Protein Data Bank (PDB). 
Careful studies of these structures revealed several common features of lipases. The first 
common feature is that all of the lipases are members of “α/β-hydrolase fold” family which 
has a core structure composing of parallel β strands which are surrounded by α helices [22-
25]. The second common feature is that lipases have an active site which is formed by a 
catalytic triad composing of serine, histidine and aspartic acid/glutamic acid amino acids. 
Although chemically similar catalytic machinery is shared by lipases and proteases, 
structurally different active sites are possessed by lipases due to the distinct orientation of the 
seryl hydroxyl group to give rise to an inverted stereochemistry of catalytic triad in lipases 
[25-27].  The third common feature is that all of the lipases have a catalytic serine residue 
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which is found in a hairpin turn between an α-helix and α-helix/β-sheet in a highly conserved 
motif of the pentapeptide G-X-S-X-G. This sequence forms a specific β-turn-α motif which is 
called the “nucleophilic elbow” [22, 23, 25].  The fourth common feature is that four binding 
pockets form the catalytic cleft of the lipases; three binding pockets hold the sn-1, sn -2 and 
sn -3 acyl chains of triacylglycerol as well as an oxyanion hole which is formed by two 
backbone amides of two residues located in the N-terminal region of the lipase and the C-
terminal of the catalytic serine [29, 30]. The last common feature is that they all have a lid or 
flap which consists of two amphiphilic helices [14] which serves to illustrate that the lipase of 
guinea-pig has a “mini-lid” composed of five amino acids [28]. 
According to Pleiss et al. (1998) from the point of geometry, the catalytic cleft of lipases can 
be catagorized into three groups which are hydrophobic crevice-like, tunnel-like and funnel-
like binding sites [31]. The binding pocket variability of lipases may contribute to different 
substrate selectivities and also determine stereoselectivityby means of the possible steric 
interaction in the cleft. 
 
1.1.6 Lipases and Industry 
 
Microbial lipases are considered as a significant group of enzymes which have 
biotechnological impact not only due to their versatile properties such as selectivity but also 
to the ability of the mass production with relatively low costs via fermentation [32]. In 
addition, microbial lipases can operate in a large variety of environmental conditions. These 
characteristics make them favorable for industrial applications. Most detergent and cosmetics 
markets, for example, depend on the specific selectivity feature of lipase. Lipases therefore 
are seen as one of the most important groups of commerical enzymes [33].  
Catalytic reactions of lipases occur in aqueous and organic media; therefore they are mostly 
attractive for solving the challenging synthesis of organic reactions [34]. Due to the broad use 
of lipases in industry lipases, they are seen as an attractive candidate for the application of 
protein engineering. Microbial lipases are a favored source for many industrial applications 
due to their extracellular nature since they can be isolated and purified relatively easily and 
thus produced at large quantities. According to scientific articles and reviews about lipases 
not requiring cofactors, stability in organic solvents, possessing wide substrate selectivity at 
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high temperatures and ionic strengths, as well as high enantioselectivity are the main reasons 
for use in industrial applications [45].  
In the food processing industry modified fats and oils, key food constituents, are one of the 
important fields of biotechnology. Lipases can be easily modified due to their lipid properties 
through changing the fatty acid chain locations in the glyceride or changing the location of 
one or more of these with novel lipases. Therefore, relatively low-priced and less favorable 
fats could be modified to a fat which has higher value [36]. To illustrate lipases are used by 
various modification of the fatty acid chain lengths to hydrolyze the milk fat and to enhance 
the flavor of cheese flavor [1]. Another example of the usage of lipases in the food industry is 
in the flavor enhancement of the bakery products by freeing short chain fatty acid chains 
using transesterification and prolonging the shelf lives. Table 1.1 depicts the other industrial 
areas where the lipases are mostly used.  
 
Table 1.1:  List of the industrial areas that lipases are used and their effects [1] 
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1.1.7 Engineering Lipases 
 
In the application of chemical catalysis there is a certain pattern should be followed by all 
enzyme catalysis. Therefore, chemical catalysis might be seen as inferior to enzyme catalysis 
under the circumstances that means of less efficiency and specificity of chemical catalysis. 
Specific products are produced in the selective nature of reactions for enzymes via applying 
enzymes as catalysts. Therefore, use of the selective nature of an enzyme might decrease 
waste products or energy consumption.  
It is the general knowledge that the function ability of enzymes and proteins depends on the 
lock and key theory. Therefore the structure and function of the lipases also depends on this 
theory. Under these circumstances protein engineering takes a crucial place leading to 
generate new lipases with altered substrate selectivities and improved stabilities. As 
mentioned in earlier sections, lipases are used in many industrial fields; therefore, lipases that 
are obtained via protein engineering research for harsh conditions such as showing activity at 
various pH scale(s), at high temperatures might breakdown the limitations of lipases if their 
native cannot cope with harsh conditions [37].  
 
1.2 Protein Engineering 
1.2.1 Background 
 
Protein engineering can be defined as the design and construction of new proteins or enzymes 
with novel or desired functions by modifying primary structure of protein by using 
recombinant DNA technology [38]. The major principles of the protein engineering are 
rational approach using three-dimensional (3D) models and random approach using directed 
evolution [39]. By applying protein engineering, it is easy to manipulate and clarify the 
folding of protein and stability or structure-function relationships [40]. Thus protein 
engineering is an important tool with crucial impact over industrial and research applications. 
In order to design the drugs for treatments, for example, protein engineering has a great 
impact in therapeutics research, whereas it also has an effect on industrial enzymes [38]. 
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1.2.2 Random and Rational Approach 
 
Design, mutagenesis and production are three major steps of protein engineering 
methodology. To start protein engineering, prior information about the structure and sequence 
of the protein or gene of interest can be required. In a rapid changing biological world, 
different methods of protein engineering are applied such as a random approach or rational 
approach to obtain desired proteins [38]. Nowadays, the most common method is known as 
recombinant DNA technologies.  
The random approach is the selection of improved proteins/enzymes from a large number of 
randomly generated variants. Generation of these variants can be obtained by either random 
aminoacid substitutions or selection/identication of these mutations and then can be screened 
according to their specific properties [41]. Random approach is also known as directed 
evolution due to the way of generation - the generation of large numbers of DNA fragments 
and library of these mutants. In a random approach, the design steps and mutagenesis are 
continued simultaneously. 
The rational approach is the guided design of novel proteins/enzymes with improved and 
desirable properties [38].  Apart from the random approach, the steps of design and 
mutagenesis are not continued simultaneously in a rational approach. With the help of three-
dimensional (crystal structure) structures of the proteins, the rational approach is determined 
such as site-directed mutagenesis or site-saturation mutagenesis. These methods of a rational 
approach are preferred according to the properties of protein of interest [42]. Thus the 
knowledge of the protein structure, which can lead to determine the specific sites for 
mutations to consider improved qualities and novel functions, is used by rational approach. In 
addition if there is only knowledge about the primary structure of the protein, then random 
mutagenesis and selection can be required for the desired protein properties [43].  
At the end approaches that are random and rational also show two different outcomes. The 
random approach mostly determines the outcomes whereas information about the structure-
function relations of the proteins can be provided by rational approach. After the design step, 
the progress is carried out with a mutagenesis step such as heterologous protein expression, 
purification of altered protein, and characterization of altered protein. 
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1.2.2.1 Mutagenesis 
 
As mentioned under previous subtitles, a rational approach is mostly used to manipulate DNA 
for protein engineering. In order for my research to start and continue, the best approach 
might be the rational approach, the site-directed mutagenesis. 
Site-directed mutagenesis is in-vitro in that it depends on replacing the certain length of the 
aminoacids into the target site or gene by applying the PCR-based technique. To carry out the 
site-directed mutagenesis, there are possible methods such as the whole plasmid single-round 
PCR method and the overlap extension PCR (OE-PCR).  Two primers with mutations, that 
should be complementary to opposite strands of the DNA template plasmid, can be required 
for whole plasmid single-round PCR. During the whole plasmid single-round PCR, the 
replication of two strands of the template should result in the generation of mutated plasmid 
without overlapping breaks. In order to obtain circular or nicked vector that contains the 
mutant gene there is a step of selective digestion. After the selective digestion, transformation 
of the vector can be carried out to repair the nick in the DNA that is the way of obtaining the 
mutated plasmid [43]. Another method is the overlap extension PCR. During the application 
of this method two primer pairs (one of the each primer pairs possesses the mutant codon as 
the mismatched sequence) can be used. The overlap extension PCR depends on two different 
PCRs. First of all two double-stranded DNA products can be obtained by using required 
primers. Generations of two heteroduplexes that have mutated sequences are obtained after 
the process of denaturation and annealing steps.  With the help of DNA polymerase the 
missing parts of the DNA length can be completed the overlapping 3’ and 5’ ends of the 
heteroduplexes. In order to amplify the mutatagenic DNA products, the second PCR of the 
overlap extension PCR can be applied with the usage of the nonmutated primer pairs [42].  
Figure 1.3 represents the overall process of the OE-PCR.  
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Figure 1.3: Principle of OE-PCR in Site-directed Mutagenesis.                                                        
Lines indicate the double-stranded DNAs with arrows representing the 5’ to 3’ orientation. 
The small black rectangle is the site of the mutagenesis. Lower case letters indicate the 
primers; upper case letters indicate PCR products. Annealing of the denaturated fragments 
and DNA polymerase enzyme extend the overlapping 3’ and 5’ ends of the heteroduplexes in 
the boxed portion of the figure. Mutant product is further amplified by additional primers. 
 
1.2.2.2 Production 
 
In the rational approach the following step of the mutagenesis is the production of the 
recombinant proteins. During the step of production of protein, desired and undesired proteins 
are totally expressed, a process which is called heterologous protein expression in various 
expression systems (in model organisms) such as Escherichia coli, Saccharomyces cerevisiae 
and Pichia pastoris. Therefore purification of desired protein takes a key role in this process.  
According to the aim of the research one of the expression systems can be chosen. In order to 
deal with post-translational modifications such as phosphorylation or glycosylation on the 
recombinant protein, the best option for eukaryotic proteins can be working with yeast 
systems. The logic behind of using Pichia pastoris is that it has a high growth rate and can 
grow on a simple, inexpensive medium. In addition, the production of Pichia pastoris can be 
done in either shake flasks or a fermenter depending on the scale of the production. AOX1 
and AOX2, that are the two alcohol oxidase genes, are a strongly inducible promoter. 
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Methanol, that is the carbon and energy source for Pichia pastoris, induces the AOX 
promoters. Introduction of the desired protein can be done under the control of the AOX1 
promoter. Therefore, the production of desired protein can be induced by the addition of 
methanol. In the yeast system, secretion of the desired protein in a growth medium highly 
facilitates protein purification. pPICZα and pPICZαA are the commercial plasmids of yeast 
systems [49]. 
Another expression system, which is most widely used system for decades in the production 
of recombinant proteins, is protein expression in E. coli. The logic behind using E. coli is that 
E. coli genetics are well understood that it is possible to generate almost unlimited quantities 
of proteins. In addition, the culturing time of the E. coli is shorter than other expression 
systems and also the expression of more than one protein is possible in E. coli [45]. The 
promoter (T7 promoter) that can be used in E. coli is different than the promoter of Pichia 
pastoris (AOX promoters).  
According to required amount of protein the scale of productions might be changed. 
Therefore various production methods can be applied such as bench-scale production, 
fermentation, and a cellular production. After the production of the recombinant proteins, 
purification is the most important step of the rational approach because of the aim of 
obtaining only the desired proteins in order to characterize and analyze the mutant proteins. 
The aim of the thesis depends on investigation of licked glycosylation; therefore, the 
expression system of Pichia pastoris is chosen in this thesis.  
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1.3 Aspergillus Niger lipase 
 
Aspergillus niger lipase is an extracellular 1,3-specific lipase with a molecular weight of 35.5 
kDa and an isoelectric point of 4.4. In addition the optimal activity of the ANL is between 
35oC-55oC for temperature whereas the optimal activity of the ANL is between 5.0-6.0 for 
pH[46].  The native Aspergillus niger lipase contains sugar content but according to previous 
reports the percentage of sugar content is variable from 2.8% to 7% [46].  
Aspergillus niger lipase is a 891-bp DNA fragment and the lipase is 297 amino acids in 
length. Although the full-length lipase gene and protein product is known, the 3D structure of 
ANL remains to be elusive. Yet in the study of Zhengyu Shu,  ANL was obtained through 
homology modeling  using the BioEdit software, lipase engineering database, PSIPRED and 
SwissModel servers [47]. According to this model, the ANL has an α/β hydrolase fold with 
GXSXG motif containing the catalytic serine. According to this model, ANL structure is 
composed of at least 30% helical  and 20% sheet secondary structures  [46]. The predicted 
structure of the ANL in the study of Shu is represented in the Figure 1.4 [47] 
It has been noted that ANL  is of great  importance in biocatalysis performed in the food 
industry, in which the lipase has been utilized as food and as a detergant additive like in 
cellulose acetylation [47]. Moreover the usage of ANL is safe in the food and pharmaceutical 
industry [48]. 
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Figure 1.4: Structure of Aspergillus niger lipase by homology modelling [47]. 
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1.3.1 Prospective Applications of Aspergillus Niger lipase 
 
Aspergillus niger lipase is one of the chief producers of commercial lipases due to its low cost 
of extraction, thermal and pH stability, substrate specificity, and activity in organic solvents. 
Most lipases are suitable as a detergent additive due to having properties of their 
thermostabilities, high activities at alkaline pH, and stabilities towards anionic surfactants. In 
addition most lipases have a role as biocatalysts and therefore novel reactions and a wide of 
variety transformations such as chemo-, region-, and enantioselective can be carried out in 
both aqueous and nonaqueous media; because they possess broad substrate tolerance, high 
stability towards temperatures and solvents, and high enantioselectivity they can be chosen by 
organic chemists.  
Nowadays, due to the catalytic behavior of lipases applications of lipases, which can be found 
in various fields of industrial microbiology and biotechnology, can be documented by 
numbers of research investigations. To illustrate, Aspergillus niger lipase has already been 
used for detergents, the oleochemical industry, synthesis of triglycerides, synthesis of 
surfactants, synthesis of ingredients for personal care products, pharmaceuticals and 
agrochemicals. Therefore, there is a lot of scope to search for newer lipases with desired 
selectivity and substrate tolerance. 
 
1.3.2 N-Linked Protein Glycosylation 
 
One of the fundamental and extensive post-translational modification is the asparagine (N)-
linked glycosylation of proteins which can result in the covalent attachment of an 
oligosaccharide onto asparagine residues of polypeptide chains. N-linked glycosylation has 
been known as a modification that can be seen in eukaryotes, but according to recent studies it 
can be also seen in prokaryotes [50]. The earlier studies in model organisms indicate that all 
three domains of life reveal that the core of N-glycosylation can be represented by three 
homologous processes. First of all glycosyltransferases can assemble the glycan from 
nucleotide-activated building blocks on a lipid anchor through the stepwise incorporation of 
monosaccharides [50]. The lipid-linked oligosaccharide is then re-oriented from the cytosolic 
to the luminal side of the eukaryotic ER membrane or of the plasma  membrane in 
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prokaryotes, where it serves as donor for glycosylation. After flipping to the luminal side of 
the ER, the lipid-linked oligosaccharide can be further extended in many eukaryotes. 
Secondly proteins with the consensus sequence for glycosylation N-X-S/T where X is not 
Pro; note that Thr is more common than Ser when translocated to the ER lumen serve as 
acceptors [50]. Thirdly the en bloc transfer of the oligosaccharide to the asparagine side chain 
of the acceptor polypeptides can be catalyzed by the oligosaccharyltransferase [50]. 
After being covalently linked to proteins, the N-glycan can be altered in eurkaryotes. This 
sequential processing is coupled to the secretory pathway and results in a species-specific or 
even cell type-specific diversity of N-linked glycans [50]. A functional view of eukaryotic N-
glycan structure is represented in Figure 1.5. 
 
 
Figure1.5: A functional view of eukaryotic N-glycan structure [50] 
The functions of N-glycosylation can be divided into groups which are extrinsic and intrinsic. 
The intrinsic functions of the N-glycosylation are that providing structural components to the 
cell wall and extracellular matrix and modifying protein properties such as stability to high 
temperature or pH. On the other hand the extrinsic functions of N-glycosylation are that 
directing trafficking of glycoproteins and mediating cell signaling such as cell-cell or cell-
matrix interactions [51].  
 Glycosylation may alter the structure of the proteins; therefore it may cause altering the 
function of the protein. According to previous studies due to the binding of the sugar to 
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protein, the structure of protein might be changed which is associated with intracellular of 
folding; therefore, it may increase the stability of the protein and the activity of N-glycan 
protein [50]. According to most previous studies, the elimination of the glycosylation site of 
the protein causes the decrease in the activity level of protein [54]. In the literature, contrary 
experimental data can also be seen. The research of Variketta, for example, indicated that the 
content of sugar was completely removed by endoglycosidase F treatment, but the 
deglycosylated enzyme retained full activity in Aspergillus niger lipase [46]. Apart from all of 
that the mutations in eighteen genes involved in N-linked glycosylation result in a variety of 
diseases which are mostly associated with nervous system [52]. 
N-linked glycosylation also has a key role in the production of therapeutic proteins in health 
industry because most of the antibodies are the N-linked glycoproteins such as Etanercept and 
Rituximab.  
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2 METHODS 
 
2.1     Prediction of N-linked Glycosylation Sites 
 
In order to determine the possible glycosylation sites, two N-glycosylations predictors are 
used which are NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/NetNGlyc/) and 
GlycoEP (http://www.imtech.res.in/raghava/glycoep/submit.html). First of all NetNglyc 1.0 
server was used, there was a limitation with this server; because the NetNglyc server predicts 
N-Glycosylation sites in human proteins using artificial neural networks that examine the 
sequence context of Asn-Xaa-Ser/Thr sequons. Therefore we decided to use another N-linked 
glycosylation predictor which was GlycoEP. According to GlycoEp information, GlycoEp 
webserver is trained and optimized using exclusively eukaryotic glycosites’s datasets and it 
can perfom predictions with very high accuracy as well as stringency for three glycosylation 
types in eukaryotes. These two predictors indicated the same glycosylation sites. The data is 
represented under the result section. 
 
2.2 Molecular Cloning 
 
A 891-bp DNA fragment indicating the Aspergillus Niger lipase (ANL) gene was amplified 
from the mature lipase clone (pPICZαA – ANL) DNA through ligation independent cloning. 
The primer sets contain EcoRI and SalI restrictions sites for directional cloning ligation and 
have sequences of; for forward (CCGGAATTCATGTTCTCTGGACGGTTT) and for reverse 
(CCGGTCGACTAGCAGGCACTCGGAAAT).  The PCR condition for amplification of the 
ANL gene is given in Table 2.1. 
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Step ºC min Cycle 
Initial Denaturation 94 3 1 
Denaturation 94 0.5 
35 Annealing 54 0.5 
Extension 72 0.75 
Final Extension 72 7 1 
Hold 4   
 
Table 2.1: PCR Profile for ANL 
4 µg of pPICZαA, the expression vector for P. Pastoris (see Appendix A1 for the map), was 
linearized by the restriction enzymes EcoRI and SalI in the reaction mixture shown in the 
Table 2.2. 
pPICZαA 50 µl 
EcoRI and SalI 2 µl 
Green Buffer 6 µl 
ddH2O 2 µl 
Volumefinal 60 µl 
 
Table 2.2: pPICZαA EcoRI and  SspI Digestion 
Agarose gel electrophoresis was carried out for linearized vector and PCR products at 100 
Volt for 20 minutes, in 1.2% agarose gels by using TBE (tris-borate EDTA) buffer system. 
Each of the fragments was extracted from the agarose gel using QIAquick Gel Extraction Kit 
following the manufacturer’s instructions (see Appendix A2). The extracted DNA fragments 
were ligated using T4 DNA Ligase. The ligation reaction was carried out at 25oC for 
overnight. The reaction mixture is as indicated in Table 2.3.  
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Vector Volume PCR Product Volume 
ddH2O 2 ddH2O 2 µl 
5X Buffer 14 µL 5X Buffer 14 µl 
T4 
Polymerase 2  µL T4 Polymerase 2 µl 
dGTP 2  µL dCTP 2 µl 
DNA 50  µL DNA 50 µl 
Vfinal 70  µL Vfinal 70 µL 
 
Table 2.3: T4 Polymerase Reaction 
 Before the setting up the ligation reaction, DNA fragments were extracted using phenol-
chloroform and precipitated using ethanol with the following protocol: 
 Product of T4 DNA polymerase reaction for vector and insert (70 µl) are completed up 
to 100 µl with ddH2O. 
 Addition of 1:1 ratio phenol/ chloroform (100 µl) into both tubes. 
 Vortex thoroughly.  
 5 minutes of centrifugation at 13,200 rpm. 
 Collect the upper (aqueous) phase. 
 Addition of 4 µL NaOAc, 10 µl LPA and 250 µl EtOH (%100). 
 Keep the tubes at -80⁰C for 20 minutes. 
 15 minutes of centrifugation at 13,200 rpm. 
 Discard the supernatant. 
 Addition of 250 µl EtOH (%70) onto the pellet. 
 10 minutes of centrifugation at 13,200 rpm. 
 Discard the supernatant. 
 Resuspend the pellet with 10 µl of ddH2O. 
Chemically competent E. coli (XL21-Blue) cells prepared and transformation of the ligation 
reaction mixture to the E.coli XL21-Blue cells was carried out as following protocol: 
 Add the annealing mixture onto 200 µl XL21-Blue competent cell. 
 Keep the mixture on ice for 20 minutes. 
 Heat shock for 1 minute at 42⁰C. 
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 Transfer the mixture on ice and incubate for 10 minutes. 
 Add 800 µl of super optimal broth with catabolite repression (SOC) onto the cells. 
 Incubate the cells at 37⁰C with 250 rpm shaking for 60 minutes. 
 Centrifuge the cells at 7000 rpm for 2 minutes. 
 Discard the supernatant. 
 Resuspend the pellet in approximately 100 µl of the remaining supernatant. 
 Spread the cells on LB agar plate with the appropriate antibiotic using glass beads. 
 Incubate the plates at 37⁰C for overnight (16-18 hours). 
Colony PCR was performed to confirm the cloning with Table 2.4. Single colonies in the 
transformation plates were selected and used as template in the PCR that had the same cycling 
profile in Table 2.1. Also the same primers in the cloning PCR were used. 
 
 
Forward Primer 1 µl 
Reverse Primer 1 µl 
Taq Polymerase Master Mix 10 µl 
ddH2O 8 µl 
Vfinal 20 µl 
 
Table 2.4: Colony PCR Reaction 
The results of the colony PCR was evaluated in 1.2% agarose gel using GeneRulerTM 1 kb 
DNA Laddder SM0311 (Fermantas, see Appendix A3 for Electrophoresis Marker Legends). 
Plasmid purifications were carried out from the colony PCR colonies according to the 
instructions given in the Qiagen Plasmid Purification Kit (see Appendix A4 for the protocol). 
For two set of colonies EcoRI and SalI digestion was performed as a confirmation such as 
recommended by Fermentas. AOX1 Forward (GACTGGTTCCAATTGACAAGC) and 
AOX1 Reverse (GCAAATGGCATTCTGACATCC) were used for sequencing by Molecular 
Cloning Laboratories (MCLAB). 
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2.3 Site-directed Mutagenesis 
 
Three mutations which are N59Q (Asparagine to Glutamine at residue 59), N150Q 
(Asparagine to Glutamine at residue 150), and N269Q (Asparagine to Glutamine at residue 
269) were generated using Overlap Extension PCR (OE-PCR). The primers of the mutation 
are demonstrated in Table 2.5. For whole mutants (N59Q, N150Q, and N269Q), two PCR 
reactions were prepared by using primers F_ANL_LIC as forward and reverse primers of the 
mutant; and forward primers of the mutant and R_ANL_LIC as reverse. These DNA 
segments were applied gel extraction from 1.2% agarose gel and used to obtain full-length 
DNA fragment by Overlap Extension PCR. The initial 15 cycles were carried out without any 
primers and the consecutive 15 cycles were performed with ANL_LIC primers. The PCR 
profile of the OE-PCR and PCR mixtures are indicated Table 2.6 and Table 2.7. 
 
 
Table 2.5: Primer Sequences for Mutagenesis 
 
 
 Q1/G1 Q2/G2 
ddH2O 9,5 µl 9,5 µl 
2X pwo MasterMix 12,5 µl 12,5 µl 
Forward Primer 1.25 µl 1.25 µl 
Reverse Primer 1.25 µl 1.75 µl 
Template 0.5 µl 0.5 µl 
Vfinal 25 µl 25 µl 
 
Table 2.6: 1st Reaction of OE-PCR  
 
 
Mutation Direction 5’-3’ Sequence 
N59Q forward CATCCCCACGCGCCGGTGATGCACCCATCGT 
reverse TTATCCACTTCCAATGCCAGGGCAGCAGCAC 
N150Q forward ACCCATCGCATCCCCACGCGCCCAGGATGCACCCATCGT 
reverse CCTGGGACGATGGGTGCATCCTGGGCGCGTGGGGATG 
N269Q forward GCGGCATCCCCATGCTGCAATGATGCACCCATCGTGCTT 
reverse TGCCAGGGCAGCAGCACGCCAACTGCTCGGCAAGTCG 
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For the 1st reaction of the OE-PCR for Q1 and G1 primer combinations, initial denaturation (3 
minutes at 94⁰C), denaturation (30 seconds at 94⁰C), annealing (30 seconds at 54⁰C), 
extension (45 seconds at 72⁰C) and the final extension (7 min at 72⁰C) are applied as 35 cycle 
for denaturation, annealing and extension. For Q2 and G2 primer combinations, initial 
denaturation (3 minutes at 94⁰C), denaturation (30 seconds at 94⁰C), annealing (30 seconds at 
54⁰C), extension (45 seconds at 72⁰C) and the final extension (7 min at 72⁰C) are applied as 
35 cycle for denaturation, annealing and extension. 
       
Q1/G1 5-10 µl 
Q2/G2 5-10 µl 
2X pwo Master Mix 25 µl 
ddH2O 10 µl 
 
Table 2.7: 2nd Reaction of OE-PCR 
After 15 cycles which was adjusted as 3 minutes at 94⁰C for initial denaturation, 30 seconds 
at 94⁰C for denaturation, 30 seconds at 54⁰C for annealing and 45 seconds at 72⁰C for 
extension; 2.5 µl F_ANL_LIC and 2.5 µl R_ANL_LIC primers were added to the reaction. 30 
seconds at 94⁰C for denaturation, 45 seconds at 53⁰C for annealing and 1 minute at 72⁰C for 
extension were performed as 30 cycles and 7 minutes at 72⁰C as final extension. The mutant 
DNA fragments were cloned into pPICZαA vector through the procedure given above for 
ANL in the section 2.1.1. 
 
2.4 Lipase Expressions and Purification 
 
After the sequence confirmations, the positive colonies of Pichia Pastoris cells were selected 
for lipase expressions. All mutants (ANL1-2, ANL2, and ANL2-3) and WT (ANL) were 
started in 5 ml cell culture in YPD at room temperature shaker.  After two days they were 
transferred into 50 ml of BMG buffer (5 ml of 10X YNB, 5 ml 10X Phosphate-Buffer, 5 ml of 
10X Glycerol, 100 µl of 500X Biotin and ddH2O) and left at 30
oC shaker with 250 rpm for 
three days. Then all of them were harvested by 10 minutes of centrifugation at 4000 rpm to 
obtain the cell pellet containing gene of interest. Each of the pellet was resuspended into 5 ml 
of BMM buffer (100 mM potassium phosphate buffer pH 6.0, 13.4 g/L yeast nitrogen base, 
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0.00004% biotin) supplemented with 1% sorbitol and methanol. After the resuspending step, 
each flask was filled up with the BMM buffer until the final volume was 50 ml and once 
again left at 30oC shaker with 250 rpm shaking. All mutants and WT were expressed in 50 ml 
cell culture using methanol as the inducer and sorbitol as the non-repressive carbon source. 
The expressions were carried out for five days by sampling every day by centrifugation at 
13,200 rpm for 2 minutes. After determining the time point for the maximal protein yield 
through analytical methods such as lipase assay and SDS-PAGE, expressions were carried out 
at higher volumes. The expression medium was similarly separated from the cells by 
centrifugation and the secretion medium was concentrated using Vivaspin 6, MWCO 10000 
concentrator.  Bradford protein assays were used to determine the quantity of the lipases by 
absorbance measurements at 595 nm. The protein solutions were kept at 4oC.   
 
2.5 SDS-PAGE  
 
SDS-PAGE (sodium dodecyl polyacrylamide electrophoresis) was carried out using the 
stacking gel at 4% and separating gel at 12.5%. Before loading, the samples were mixed with 
SDS sample buffer and boiled at 95oC for 10 minutes. The gel was run for 2 hours at 120 
Volts and the protein bands were visualized after coomassie staining.  
 
2.6 Fluorescent Lipase Assays 
 
Lipase activity was measured with fluorescent assays in 96-well black micro-titer plate by 
using substrate and 4MU-caprylate. Different concentrations of purified lipases were assayed 
in a reaction medium which contains 100 mM Tris-Cl as a buffer at ph 7.25. 4MU-
fluorescence was measured by Fluoroskan Ascent (Thermoscientific) with 355 nm excitation 
wavelength and 460 nm emission wavelength every minute for 1 hour in a kinetic manner. 
The software of the fluorometer was used to determine the initial velocities and the 
measurements were performed in duplicates. 
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2.6.1 Thermostability Assay 
 
Purified proteins were used in a series of enzymatic assays to profile their thermostability by 
quantifying residual activity. For this purpose, the lipases were incubated at 35-55°C for 30 
minutes. The amount of the lipase that has a linear relationship with relative fluorescence was 
determined prior to assays and 10 nM of lipases were used in the final reaction mixture. The 
residual activity was quantified in enzyme assays using 4MU-caprylate as the substrates. The 
enzyme activities were recorded from duplicate measurements and the assays were performed 
in 0.1 mM Tris-Cl pH 7.25 at room temperature using 250 µM substrate. The percent activity 
was calculated by adjusting the maximum activity to 100%. 
 
2.7 Enzymatic Cleavage of Glycosylation 
 
Two commercially available enzymes, Endo Hf (New England Biolabs) and PNGase F (New 
England Biolabs) were used for enzymatic degradation of glycosyl moieties of the modified 
residues. 
For the treatment of EndoHf, 1-20 µg of glycoprotein was combined with 1 µl of 10X 
Glycoprotein Denaturing Buffer and then this mixture (glycoprotein) was denatured by 
heating reaction at 100oC for 10 minutes. After this step, the previous product, and 2 µl of 
10X G5 Reaction Buffer, 2 µl of Endo Hf and 6 µl of ddH2O were combined. This reaction 
was left for 1 hour at 37oC. 
For the treatment of PNGase F, 1-20 µg of glycoprotein was combined with 1 µl of 10X 
Glycoprotein Denaturing Buffer and then this mixture (glycoprotein) was denatured by 
heating reaction at 100oC for 10 minutes. After this step, the previous product, and 2 µl of 
10X G7 Reaction Buffer, 2 µl of PNGase, 2 µl of %10 NP and 4 µl of ddH2O were combined. 
This reaction was left for 1 hour at 37oC. 
Furthermore SDS-PAGE (sodium dodecyl polyacrylamide electrophoresis) was carried out 
for these samples to confirm whether a difference exists. Stacking gel contained 4% 
polyacrylamide and separating gel contained 12.5% polyacrylamide. The buffer exchange of 
the lipases against deionized water was carried out by 10 kDa filter concentrators (Millipore). 
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3 RESULTS 
 
3.1 Prediction of N-linked Glycosylation Sites 
 
In order to determine the possible glycosylation sites, two N-glycosylations predictors are 
used which are NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/NetNGlyc/) and 
GlycoEP (http://www.imtech.res.in/raghava/glycoep/submit.html).  
The result of NetNGlyc is represented in Figure 3.1 whereas the result of GlycoEP is 
represented in Figure 3.2.  
First of all NetNglyc 1.0 server was used yet with a limitation because the NetNglyc server 
predicts N-Glycosylation sites in human proteins using artificial neural networks that examine 
the sequence context of Asn-Xaa-Ser/Thr sequons. Therefore we decided to use another N-
linked glycosylation predictor which was GlycoEP. According to GlycoEp information, 
GlycoEp webserver is trained and optimized using exclusively eukaryotic glycosites’s 
datasets and it can predict with very high accuracy as well as with high stringency for three 
glycosylation types in eukaryotes. These two servers predicted the same glycosylation sites. 
According to both results, N-linked glycosylation sites were found in motif sequences of Asn-
Xaa-Ser/Thr sequons. We believed that GlycoEP is more reliable than the NetNGlyc 1.0 
server; because GlycoEP is the predictor which examines the yeast systems. After obtaining 
these data, we designed our primers to eliminate the possible glycosylation sites positions 59, 
150, 269. Asparagine is the aminoacid that takes a place at each position and this aminoacid 
was substituted with glutamine. Because the biochemical structures of asparagine and 
glutamine are very similar, it would be a complementary mutation for the overall structure yet 
a loss of function regarding glycosylation.  
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Figure 3.1: The results of NetNGlyc 1.0 server 
 
According to Figure 3.1 the position of 59th aminoacid, the position of 150th aminoacid and 
the position of 269th aminoacid are the crucial point for the rest of this research. In Figure 3.1 
the blue lines indicate the potential sites of glycosylation, whereas the red line indicates the 
threshold which means that there is a low possibility if the blue lines are under this red line. 
Therefore the position of 59th aminoacid is the most probable site to be glycosylated while the 
position of 269th aminoacid is the least.  
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Figure 3.2: The results of GlycoEP 
According to Figure 3.2 the position of 59th aminoacid, the position of 150th aminoacid and 
the position of 269th aminoacid are the crucial point for the rest of this research. In Figure 3.2 
the highlighted green colored text indicates predicted glycosylation sites. Therefore the 
position of 59th aminoacid and the position of 150th aminoacid 269th aminoacid are selected 
for mutagenesis studies.  
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3.2 Molecular Cloning of ANL2, ANL1-2, ANL2-3 
Mutations 
 
 
Figure 3.3: Agarose Gel Electrophoresis Results of amplifications of ANL mutants which has 
891 base-pairs and amplified by using ANL_LIC primer pairs. Analysis was made in agarose 
gel under 100V for 20 minutes. 
Mutant ANL genes and the linearized expression vector pPICZαA were separated in agarose 
gel electrophoresis according to their sizes (Figure 3.3). The results indicated the presence of 
linearized pPICZαA expression vector at 3593 bp and the amplified ANL mutants at 891 bp. 
Prior to annealing reactions, another agarose gel was used to visualize the T4 DNA 
polymerase treated samples to determine the appropriate amounts of pPICZαA vector and 
ANL mutants for annealing reaction. 
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 Figure 3.4: Cloning Confirmations of ANL2, ANL1-2, and ANL2-3 Mutants by 
Colony PCR. 
Colony PCR was performed using F-ANL-Eco and R-ANL-Sal primers to forty single 
colonies obtained from the transformation plates. Analysis was made in agarose gel under 
100V for 20 minutes. 
40 single colonies were selected from the transformation plates and colony PCR was 
performed. 28 of 40 colonies indicated the presence of the insert and confirmed to contain the 
mutant gene (Figure 3.4). 
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Figure 3.5: Cloning Confirmations of ANL Mutants by Double-Digest. 
Confirmation of the pure plasmids of ANL2, ANL1-2, ANL2-3 mutations are performed 
using EcoRI and SalI digestion enzymes and the analysis were made in agarose gel under 
100V for 20 minutes.  
 
Double digestion of recombinant plasmids was performed using EcoRI and SalI restriction 
enzymes and confirmed the presence of mutant ANL genes (Figure 3.5). 
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Figure 3.6: Cloning Confirmations of ANL1 Mutant by Sequencing 
Reverse and forward readings are performed and mutated sites are indicated by black 
brackets.  
 
The sequencing result for the ANL1 mutant confirmed the cloning by site directed 
mutagenesis. Asparagine amino acid at residue 59 was converted to glutamine amino acid 
which is indicated in Figure 3.6 with a black bracket. 
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Figure 3.7: Cloning Confirmations of ANL1-2 Mutant by Sequencing 
Reverse and forward readings are performed and mutated sites are indicated by black 
brackets.  
 
The sequencing result for the ANL1-2 mutant confirmed the cloning by site directed 
mutagenesis. Asparagine amino acids at residue 59 and 150 were converted to glutamine 
amino acids which are indicated in Figure 3.7 with a black bracket. 
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 Figure 3.8: Cloning Confirmations of ANL3Mutant by Sequencing 
Reverse and forward readings are performed and mutated sites are indicated by black 
brackets.  
 
The sequencing result for the ANL2-3 mutant confirmed the cloning by site directed 
mutagenesis. Asparagine amino acids at residues 150 and 269 were converted to glutamine 
amino acids which are indicated in Figure 3.8 with a black bracket. 
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3.3  Expressions and Purifications of ANL (WT), ANL2, 
ANL1-2 and ANL2-3 Mutant Lipases 
 
 
Figure 3.9: Expressions of ANL (WT), ANL2, ANL1-2, and ANL2-3 Mutations. Whole cell-
fraction intervals were analyzed in 12% SDS-PAGE which was stained with coomassie dye. 
The gel indicates: Marker, WT t0, purified WT, purified ANL2, purified ANL1-2, purified 
ANL2-3, WT, ANL2, ANL1-2, and ANL2-3 samples 
 
Aspergillus niger lipase is 35-40 kDa protein and P. pastoris expression of ANL, ANL2, 
ANL1-2 confirmed the presence of the recombinant ANL around 30-35 kDa on the SDS-
PAGE (Figure 3.9). All of the expressions were performed with shake flasks. Although the 
expression was repeated more than twice, it was observed that the expression levels of the 
recombinant ANL often fluctuated, suggesting that shake flask expressions were not 
consistent. Although there were variations between two identical expression trials, the 
recombinant ANL was able to be produced at high quantity. Such variations could be highly 
similar due to the shake flask system itself. Unlike to the controlled environments like 
fermentation systems, shake flask systems are prone to produce variations in the pH and 
temperature of expression media. Nevertheless ANL, ANL2, ANL1-2 were successfully 
expressed. Yet expression levels of ANL2-3 were too low compared with the other three 
lipases.  
36 
 
 
Figure 3.10: Column Purification for the ANL (WT), ANL2, ANL1-2, and ANL2-3 
Mutation. 
Marker / ANL E1 / ANL E2/ ANL E3/ ANL2 E1/ ANL2 E2/ ANL2 E3/ ANL1-2 E1/ ANL1-
2 E2/ ANL1-2 E3/ ANL2-3 E1/ ANL2-3 E2/ ANL2-3 E3 
 
The purification gel for the ANL mutants confirmed the protein expression, which was shown 
in the input protein and purely, eluted proteins (30-35 kDa) whereas the purification gel for 
the ANL confirmed the protein expression, which was shown in the input protein and purely, 
eluted proteins (35-40 kDa)   in the elution steps (Figure 3.10). 
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3.4  EndoHf Treatment of ANL (WT), ANL2, ANL1-2 and 
ANL2-3 Mutant Lipases 
 
Figure 3.11: Expressions of ANL (WT), ANL2, ANL1-2, and ANL2-3 Mutations after 
EndoHf treatment. Whole cell-fraction intervals were analyzed in 12% SDS-PAGE which 
was stained with coomassie dye. The gel indicates: Marker, WT t0, purified WT, purified 
ANL2, purified ANL1-2, purified ANL2-3, WT, ANL2, ANL1-2, and ANL2-3 samples 
After the EndoHf treatment the regular pattern of the ANL proteins were lost and the size of 
protein bands was moved to 40 kDa. Moreover the upper bands which are around 70 kDa 
correspond to the EndoHf enzyme in the Figure 3.11.  
3.5 Characterization of ANL2, ANL1-2, and ANL2-3 
Mutants Lipases 
3.5.1 Determination of the Linear Range for Fluorescent Lipase Assays 
ANL is 39 kDa and its molar concentration is equal to 25 µM at 1mg/ml. Fluorescent lipase 
assay by using 4MU-caprylate as substrate was performed to diluted proteins at pH 7.25 and 
room temperature. Linear range was determined between 1 µg/ml and 0.1 µg/ml, which 
correspond to 25 nM and 2.5nM, respectively. Therefore, 10 nM, which corresponds to 390 
ng/ml, was used in the fluorescent lipase assays. 20 µl of enzyme solutions were used in all 
assays.  
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Figure 3.12:The result of enzyme activity assay.Order: Blank, WT, ANL2, ANL1-2, ANL2-3 
 
Figure 3.13:The result of enzyme activity assay.Order: Blank, WT, ANL2, ANL1-2, ANL2-3 
Bradford protein assays were applied to determine the concentration of the wild type ANL, 
and mutations of ANL2, ANL1-2, and ANL2-3 proteins, which were measured with 
spectrophotomer (ELISA reader) at 595 nm. The concentration of wild type ANL protein was 
measured as 25 mg/ml; ANL2 protein was 56 mg/ml; ANL1-2 was 81 mg/ml; and ANL2-3 
protein was 63 mg/ml. All proteins were diluted to 0.39 µg/ml to reach the linear range in 
fluorescent lipase assays. 
3.5.2 Thermostability Assay 
 
Figure 3.12: Thermostability Assay for WT, ANL2, ANL1-2 and ANL2-3. 
Thermostability assay was performed in 0.1 mM Tris-Cl, pH 7.25 at given temperatures 
(30ºC-55ºC) using 250 µM substrate (4MU-caprylate). Percent activity was demonstrated and 
the highest activity for each mutant was set to 100%. 
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Results of the thermostability assay indicated that the wild type ANL shows the highest 
activity at 30ºC and the percent hydrolysis is between 66-93% at other temperatures. 
However, mutants of ANL2, ANL1-2 and ANL2-3 show lower thermostability at 30ºC 
compared to wild type ANL. Mutants of ANL2, ANL1-2 and ANL2-3 show the highest 
activity at 30ºC and the percent hydrolysis is between 67-98% at other temperatures.  Mutant 
ANL1-2 has higher thermostability compared to WT and other mutants (Figure 3.12). On the 
other hand thermostability assay shows that mutant ANL2 can conserve its thermostability 
more than WT and other mutants at various temperatures. Overall, although slight changes 
were observed in thermostability of ANL mutants with respect to the native ANL, the overall 
thermostability of the native ANL was not affected at all by any of these mutations. In other 
words, all of the lipases showed the highest activity between 30-45°C. 
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4 DISCUSSION AND CONCLUSION 
 
 
As with many recombinant proteins produced in eukaryotic hosts, glycosylation of proteins is 
an important issue with respect to the fact that this kind of modification in the protein 
sequences might affect functionality and stability [57]. Taking the advantage of being an 
eukaryotic species, P. pastoris also possesses protein synthesis pathway with the performance 
of higher eukaryotic protein modifications like glycosylation [58, 59]. N-glycosylation is the 
attachment of oligosaccharides to specific asparagine residues within the consensus sequence 
Asn-X-Ser/Thr.   Aspergillus niger lipase (ANL) is an important biocatalyst in the food 
processing industry [46]. ANL displays particularly positional selectivity toward the one- and 
three- positions of the glycerol moiety. It is also regarded as safe by the Food and Drug 
Administration of the United States of America, which makes it a conventional food additive 
in the food processing industry. Recently, ANL has also been used as a detergent additive, 
and used many other organic synthesis reactions [55, 56]. Much research on ANL has been 
concentrated on its production, purification, characterization [46, 47, 55, 56]. Here we aimed 
to determine the impacts of N-linked glycosylation of ANL in Pichia pastoris. 
First of all possible glycosylation sites were determined via NetNGlyc 1.0 server and 
GlycoEP server. These two servers indicated the same locations (positions 59, 150, and 269) 
for N-linked glycosylation which were facilitator to determine the possible sites.  From this 
point forth we decided to create primers to alter the asparagine to glutamine in order to 
investigate the effect of glycosylation while preserving the structure of the protein.  
In order to obtain and characterize proteins which carry our desired sequences, the steps were 
followed such as site-directed mutagenesis, lipase heterologous lipase expression, lipase 
column purification via nickel-coated beads, fluorescent lipase assays and EndoHf treatment. 
The results indicated that mutations possess glycosylation patterns different than the native 
lipase. According the SDS-PAGE analysis, native ANL was observed at 35-40 kDa with a 
smear appearance, while the mutant that contains N150Q mutation was between 30-35 kDa 
and the other mutants did not change the native features. Incomplete separation of the 
components can lead to overlapping bands which is known as smear appearance. According 
to literature, the native ANL has various lengths; therefore it is highly possible to have smear 
appearance even after purification procedure. This result indicates that mutation in the 150th 
aminoacid has a significant effect to alter glycosylation of ANL. After EndoHf treatment, the 
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smear appearances of the native the mutants were disappeared, and all of the proteins were 
observed as single band at 35 kDa. According to enzyme activity assay, at the same 
concentration of enzyme was applied for an analysis. The results showed that activities of 
ANL2 and the wild type were equal to each other whereas the activity of ANL1-2 was higher 
(1.5 fold) than the activity of wild type. The thermostability results showed that all of the 
lipases including the native ANL had the maximal activity at 30-45°C, indicating that the 
mutations did not have any effect on thermostability of the native ANL until 50oC; but 
thermostability of ANL-2 mutant was higher than the wild type ANL at 55oC. This situation 
might stem from the similar biochemical properties of asparagine and glutamine, both of 
which are polar amino acids.  N-linked glycosylation site (N150Q) in ANL had a major 
impact in glycosylation of ANL in P. pastoris, while the other two mutations (N59Q, N269Q) 
were not included in glycosylation mechanism. As predicted (Figure 3.1) using glycosylation 
servers, this site was the most promising site to be glycosylated in P. pastoris. In line with this 
expectation, we observed that the mutants containing N150Q substitution showed limited 
glycosylation compared with the native lipase. On the other hand, two other predicted sites 
(N59Q and N269Q) did not have any impacts on the glycosylation of native ANL. 
Considering that the sites were predicted less confidently than N150Q, it was indeed expected 
that N59Q and N269Q did not show any significant effects on glycosylation of native ANL. 
Basically, these results confirm that the native ANL is prone to glycoslyation at N150Q, while 
it is not at N59Q and N269Q. 
The commercial exploitation of lipases in particular has traditionally been hampered by their 
inadequate stability and the limitations imposed by reaction conditions (neutral buffers, 
moderate temperature and pH stability, and so on) [60]. However, the recent developments in 
biocatalysis in unconventional media, especially organic solvents [6], transformed the 
industrial perception of enzymes as very delicate catalysts, generally unsuitable for large-
scale chemical synthesis. Most of the commercially available detergents have proteases as 
additives [61]. The resistance of our enzyme toward proteases is another property which may 
be of industrial importance as there is a growing interest to engineer lipases to be protease-
resistant for use in detergents [61]. The lipase purified by us may be suitable for some of the 
above biotransformations. Finally, the scope of this thesis could be used to generate mutations 
with altered post-translational modifications and thus altered stability. As a result, the findings 
of this thesis impose would impose implications in enzymology which aims to design 
enzymes with optimal features.  
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A.1 Expression Vector Maps 
 
 
 
Figure A.1: Expression Vector Map 
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A.2 QIAquick Gel Extraction Kit 
QIAGEN- QIAquick Gel Extraction Kit Protocol: 
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. 
2.  Weigh the gel slice in a colorless tube. Add 3 volumes Buffer QG to 1 volume gel (100 mg 
~ 100 μl). For >2% agarose gels, add 6 volumes Buffer QG. 
3. Incubate at 50°C for 10 min (or until the gel slice has completely dissolved). Vortex the 
tube every 2–3 min to help dissolve gel. 
4. After the gel slice has dissolved completely, check that the color of the mixture is yellow 
(similar to Buffer QG without dissolved agarose). If the color of the mixture is orange or 
violet, add 10 μl 3 M sodium acetate, pH 5.0, and mix. The color of the mixture will turn 
yellow. 
5. Add 1 gel volume of isopropanol to the sample and mix. 
6. Place a QIAquick spin column in a provided 2 ml collection tube or into  a vacuum 
manifold. 
7. To bind DNA, apply the sample to the QIAquick column and centrifuge for 1 min or apply 
vacuum to the manifold until all the samples have passed through the column.  Discard flow-
through and place the QIAquick column back into the same tube. For sample volumes of 
>800 μl, load and spin/apply vacuum again. 
8. If the DNA will subsequently be used for sequencing, in vitro transcription, or 
microinjection, add 0.5 ml Buffer QG to the QIAquick column and  centrifuge for 1 min or  
apply vacuum.  Discard flow-through and place the QIAquick column back into the same 
tube. 
9. To wash, add 0.75 ml Buffer PE to QIAquick column and centrifuge for 1 min or apply 
vacuum.  Discard flow-through and place the QIAquick column back into the same tube. 
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Note: If the DNA will be used for salt-sensitive applications (e.g., sequencing, blunt-ended 
ligation), let the column stand 2–5 min after addition of Buffer PE. 
10. Centrifuge the QIAquick column once more in the provided 2 ml collection tube for 1 min 
at 17,900 xg (13,000 rpm) to remove residual wash buffer. 
11. Place QIAquick column into a clean 1.5 ml microcentrifuge tube. 
12. To elute DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the center of the 
QIAquick membrane and centrifuge the column for 1 min. For increased DNA concentration, 
add 30 μl Buffer EB to the center of the QIAquick membrane let the column stand for 1 min, 
and then centrifuge for 1 min. After the addition of Buffer EB to the QIAquick membrane, 
increasing the incubation time to up to 4 min can increase the yield of purified DNA. 
13. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading Dye to 5 volumes 
of purified DNA. Mix the solution by pipetting up and down before loading the gel. 
 
 
 
 
 
 
 
 
51 
 
A.3 Electrophoresis Marker Legends 
 
Figure A.3: Electrophoresis Marker Legends 
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A.4 QIAGEN Plasmid Purification Kit 
QIAGEN- Plasmid DNA Purification Kit Protocol: 
1. Resuspend pelleted bacterial cells in 250 µl Buffer P1 and transfer to a 1.7ml 
microcentrifuge tube. 
No cell clumps should be visible after resuspension of the pellet. The bacteria should be 
resuspended completely by vortexing or pipetting up and down until no cell clumps remain. 
2. Add 250 µl Buffer P2 and mix thoroughly by inverting the tube 4–6 times. 
Mix gently by inverting the tube. Do not vortex, as this will result in shearing of genomic 
DNA. If necessary, continue inverting the tube until the solution becomes viscous and slightly 
clear. Do not allow the lysis reaction to proceed for more than 5 min. If  LyseBlue has been 
added to Buffer P1 the cell suspension will turn blue after addition of Buffer P2. Mixing 
should result in a homogeneously colored suspension. If the suspension contains localized 
colorless regions or if brownish cell clumps are still visible, continue mixing the solution until 
a homogeneously colored suspension is achieved. 
3. Add 350 µl Buffer N3 and mix immediately and thoroughly by inverting the tube 4 – 6 
times. Keep on ice for 10 minutes. 
To avoid localized precipitation, mix the solution thoroughly, immediately after addition of 
Buffer N3. The solution should become cloudy. If LyseBlue reagent has been used, the 
suspension should be mixed until all trace of blue has gone and the suspension is colorless. 
4. Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge. A 
compact white pellet will form. 
5. Apply the supernatants from step 4 to the QIAprep spin column by decanting or pipetting. 
6. Centrifuge for 30–60 s. Discard the flow-through. 
7. Wash QIAprep spin column by adding 0.75 ml Buffer PE and centrifuging for 30–60s. 
8. Discard the flow-through, and centrifuge for an additional 1 min to remove residual wash 
buffer. 
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Important: Residual wash buffer will not be completely removed unless the flowthrough is 
discarded before this additional centrifugation. Residual ethanol from Buffer PE may inhibit 
subsequent enzymatic reactions. 
9. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute DNA, add 50 µl 
Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the center of each QIAprep spin column, let 
stand for 1 min, and centrifuge for 1 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
